« FDA Approvals - GTx Announces Removal of Full Clinical Hold By FDA for | Main | FDA Statement on USDA Announcement of Positive BSE Test Result »

2012 BIO International Convention to Highlight the FDA and Regulatory


2012 BIO International Convention to Highlight the FDA and Regulatory Environment
The U.S. regulatory environment strongly impacts innovation and the development of new drugs and biologics. With this in mind, the Achieving Regulatory Approval and Compliance educational track at the 2012 BIO International Convention will tackle the most pressing regulatory issues facing the industry, specifically the reauthorization of the Prescription Drug User Fee Act , implementation of the ...

EtQ Announces Its Participation in SAP EcoHub Solution Marketplace
SAP EcoHub Delivers Added Value to Customers by Accelerating Discovery, Evaluation and Purchase of Trusted Partner Solutions Such as EtQ Reliance Connector That Complement SAP OfferingsFarmingdale, NY (PRWEB) April 10, 2012 EtQ, a leader in enterprise quality, FDA compliance and environment, health and safety (EHS) management software solutions, today announced its participation in the SAP ...
 

©2006 FDA-News.com. All rights reserved.